The C-type lectin-like receptor CD161 is expressed by lymphocytes found in human gut and liver, as well as blood, especially natural killer (NK) cells, T helper 17 (Th17) cells, and a population of unconventional Tcells known as mucosalassociated invariant T (MAIT) cells. The association of high CD161 expression with innate T-cell populations including MAIT cells is established. Here we show that CD161 is also expressed, at intermediate levels, on a prominent subset of polyclonal CD8 þ T cells, including antiviral populations that display a memory phenotype. These memory CD161 int CD8 þ Tcells are enriched within the colon and express both CD103 and CD69, markers associated with tissue residence. Furthermore, this population was characterized by enhanced polyfunctionality, increased levels of cytotoxic mediators, and high expression of the transcription factors T-bet and eomesodermin (EOMES). Such populations were induced by novel vaccine strategies based on adenoviral vectors, currently in trial against hepatitis C virus. Thus, intermediate CD161 expression marks potent polyclonal, polyfunctional tissue-homing CD8 þ T-cell populations in humans. As induction of such responses represents a major aim of T-cell prophylactic and therapeutic vaccines in viral disease and cancer, analysis of these populations could be of value in the future.
INTRODUCTION
The phenotypic complexity contained within the CD8 þ T-cell compartment, conventionally considered a relatively uniform ''cytotoxic'' population in contrast to multiple CD4 þ T helper (Th) subsets, is being increasingly appreciated. In addition to the presence of unconventional T cells within the CD8 þ pool, 1 the identification of tissue-resident memory (T RM ) cells, present within tissues such as skin and gut where they can provide rapid protection, [2] [3] [4] is important in aiding the study of both pathophysiology and rational vaccine design. Understanding these functional distinctions, and identifying the markers that define them, is important in determining favorable immune outcomes in both disease and therapeutic/vaccination strategies.
CD161, or KLRB1, is a C-type lectin-like receptor expressed by the majority of natural killer (NK) cells 5 and in a subset of T cells, 6 and is particularly enriched in populations found in the gut and liver. [7] [8] [9] Analysis of CD8 þ T cells expressing high levels of this marker revealed a CD8 þ T-cell subset analogous to CD4 þ Th17 cells, 9 subsequently identified to comprise a population of semi-invariant T cells known as mucosalassociated invariant T (MAIT) cells. 10 MAIT cells express the T cell receptor (TCR) Va7.2-Ja33/12/20, are restricted by the nonclassical class Ib molecule major histocompatibility complex (MHC)-related 1 (MR1), and are enriched at mucosal sites. [11] [12] [13] Binding of CD161 to its ligand lectin-like transcript 1 (LLT1) has been described to have both inhibitory [14] [15] [16] and costimulatory 14, 16, 17 effects. Yet, independently of function, CD161 has been applied as a marker of type 17 phenotype across all T cells. 18 More recently, we have also described this molecule to mark T cells with an enhanced innate ability to respond by a TCR-independent mechanism to interleukin (IL)-12 and IL-18. 19 Although CD8 þ T cells expressing high levels of CD161 (CD161 hi /CD161 þ þ ) predominantly comprise MAIT cells, a population of CD8 þ T cells expressing lower, or intermediate, levels of CD161 (CD161 int /CD161 þ ) is also present in the circulation. 6, 9, 10 The phenotypic characteristics and immunological function of this CD161 int CD8 þ T-cell population is yet to be defined. Although CD161 is associated with the ability to express IL-17, 18 secretion of this cytokine among CD8 þ T cells is restricted to the CD161 hi subset, and was not evident from the CD161 int CD8 þ population. 9 Here, we investigated the phenotype, function, and mucosal association of this novel CD8 þ T-cell population.
RESULTS

CD161 is expressed by a subset of memory CD8 þ T cells
The NK cell marker CD161 is expressed by a subset of CD8 þ CD3 þ lymphocytes, 5 and defines three populations within the peripheral blood: CD161 high (CD161 hi ), CD161 intermediate (CD161 int ), and CD161 negative (CD161 neg ) ( Figure 1a) . Approximately equal percentages of CD161 hi and CD161 int were observed in healthy adults (mean 10.60% and 11.68%, respectively). Although these populations did express other NK cell receptors, expression of further NK-associated markers tested here were not specific to any of these populations (Supplementary Figure S1 online). The majority of CD161 hi CD8 þ T cells express the Va7.2 TCR characteristic of MAIT cells, as described elsewhere, 10, 13, 20 that display semiinvariant TCR expression of Va7.2-Ja33/12/20 13 with oligoclonal Vb expression. 1 However, unlike CD161 hi MAIT cells the CD161 int CD8 þ T-cell subset was predominately Va7.2 À (Figure 1a) . Furthermore, the CD161 int CD8 þ T-cell subset displayed polyclonal Vb expression in a similar manner to CD161 neg ( Figure 1b) . The differentiation phenotype of CD161 int CD8 þ T cells was investigated using the markers CCR7 and CD45RA to divide T cells into naive (T N : CCR7 þ CD45RA þ ), effector memory (T EM : CCR7 À CD45RA À ), central memory (T CM : CCR7 þ CD45RA À ), and terminally differentiated memory (T EMRA : CCR7 À CD45RA þ ) subsets. 21 Whereas approximately a quarter of CD161 neg cells displayed a naive phenotype, only a very small percentage (mean 3.59%) of CD161 int were CCR7 þ CD45RA þ , with the vast majority displaying a memory phenotype as for CD161 hi cells ( Figure 1c) . As expected, CD161 hi CD8 þ T cells displayed an almost uniform T EM phenotype. 22 Few CD8 þ T cells with T CM phenotype were observed, as described elsewhere. 23 On the other hand, T EM and T EMRA subsets were found in both the CD161 int and CD161 neg populations ( Figure 1d ). There was no significant difference in the percentage of either T EM or T EMRA subsets between the CD161 int and CD161 neg populations, suggesting that expression of CD161 (or loss of expression) is not associated with differentiation state.
CD161 expression was, therefore, largely restricted to memory cells within the adult circulation. To investigate the differentiation phenotype of the CD161 int CD8 þ population in early life, the same analysis was performed on peripheral blood mononuclear cells (PBMCs) from 24-month-old donors. Interestingly, although a larger percentage of the CD161 int population displayed a naive (CCR7 þ CD45RA þ ) phenotype compared with adult blood, the majority (489%) were already memory in phenotype (Figure 1e) , as seen in the CD161 hi population. In contrast, the majority of CD161 neg CD8 þ T cells were naive. Again, CD161 int CD8 þ memory T cells were composed of both T EM and T EMRA subtypes (Figure 1f) , with no difference in distribution between the two subsets, but a significantly (Po0.0001) greater proportion of the CD161 neg population displayed a T CM phenotype compared with CD161 int at this age. 
CD161
hi MAIT cells have previously been described to be enriched within the gut lamina propria 12 and the liver 9,10 in humans. We similarly examined for the presence of the CD161 int CD8 þ T-cell population within healthy pretransplant liver and normal adjacent colonic tissue, derived from surgery for colorectal cancer. Due to the lack of an obvious CD161 hi population by flow cytometry, tissue CD8 þ T cells were divided based upon expression of CD161 and Va7.2, and compared with peripheral blood (Figure 2a) . As expected, CD161 þ Va7.2 þ cells, corresponding to MAIT cells, were a major population within the liver. 24 However, CD161 þ Va7.2 À CD8 þ T cells were also present in similar proportions to both MAIT (CD161 þ Va7.2 þ ) and CD161 À CD8 þ T cells within the liver in the limited number of samples investigated here. In contrast, the majority of CD161-expressing CD8 þ T cells in the colon were CD161 þ Va7.2 À T cells comprising approximately a third (mean 32.24%) of CD8 þ T cells, with CD161 þ Va7.2 þ MAIT cells present in low numbers. As this CD161 þ Va7.2 À population represents CD161 int CD8 þ T cells (Figure 1a) , this demonstrated the CD161 int CD8 þ T-cell population to be enriched within tissues compared with blood, including the colon where they comprise the majority of CD161 þ cells.
Analysis of the inflammatory infiltrate in patients with inflammatory bowel disease (IBD), however, revealed a significant (Po0.001) reduction in the percentage of CD161 þ memory CD8 þ T cells in biopsies of inflamed tissue compared with noninflamed and control tissue (Figure 2b ). This is evident in comparison with both matched and nonmatched inflamed tissue, and in both Crohn's disease and ulcerative colitis (Supplementary Figure S2) . This CD161 þ CD8 þ T-cell population was enriched for expression of CD103 (Figure 2c) , an integrin preferentially expressed by human intestinal intraepithelial lymphocytes 24 and a marker of residence in T RM cells of mucosal tissues including the intestine, 4, 25 with expression thought to result from signals received within the gut. 4, 26 Accordingly, IBD inflamed tissue was associated with an increase in the percentage of CD103 À cells compared with noninflamed tissue, the majority of which were also CD161 À (Figure 2d) . A corresponding specific neg CD8 þ T-cell subsets expressing each TCR Vb chain as determined by flow cytometry (n ¼ 10). Flow cytometric analysis of CCR7 and CD45RA expression was used to divide CD8 þ CD3 þ lymphocytes into naive (CCR7 þ CD45RA þ ) and memory subsets in peripheral blood from adults (c,d) and 24 month olds (e,f). Memory cells were further subgated into central memory (T CM ; CCR7 þ CD45RA À ), effector memory (T EM ; CCR7 À CD45RA À ), and terminal effector memory (T EMRA ; CCR7 À CD45RA þ ) subtypes (n ¼ 16). ****Po0.0001, NS, not significant by one-way analysis of variance (ANOVA) with Tukey's multiple comparisons test. Data are represented as mean±s.e.m. dilution of the CD161 þ , and in particular the CD161 þ CD103 þ , population was observed.
Together with CD103, CD69 has also been described as a marker of tissue retention and of T RM populations. 23, 27 We therefore examined CD8 þ T-cell subsets for CD69 expression within the gut and found the majority (mean 93%) of CD161 int and CD161 neg subsets, as determined by flow cytometry, with background subtraction of geoMFI in fluorescence minus one samples, and naive (CCR7 þ CD45RA þ ) cells excluded (n ¼ 7). *Po0.05, **Po0.01, ***Po0.001, NS, not significant by paired t-test. Normalized signal intensities for expression of transcripts for IL18R1, CXCR6, ABCB1 (MDR1), and ZBTB16 (PLZF) and statistical significance from mRNA microarray expression analyses after normalization and correction for multiple testing, **Po0.01, ****Po0.0001. Floating bars show minimum and maximum values, with a line at the mean. Table S1 ). A total of 952 genes were identified to be significantly differentially expressed (Po0.01, 42-fold change), illustrated by the heatmap (Figure 3c and Supplementary Table S1 ). These transcripts included genes for both subunits of the IL18R (IL18R1 and IL18RAP), CXCR6, MDR1 (ABCB1), and PLZF (ZBTB16). The expression level of these markers was therefore examined by flow cytometry. This showed a higher percentage of the CD161 int , when compared with the memory CD161 neg , CD8 þ T-cell population to be positive for each marker. However, as there appeared to be a gradient of expression levels, the average level of expression (geometric mean fluorescence intensity (geoMFI)), with background fluorescence minus one sample levels subtracted, was analyzed. Although differences observed were modest, this demonstrated significant increased expression of IL-18Ra (Po0.05), CXCR6 (Po0.001), MDR1 (Po0.01), and PLZF (Po0.01) within the CD161 int CD8 þ T-cell population that reflected microarray results for gene expression (Figure 3d) .
A CD161 þ Va7.2 À population was also evident among CD8 þ T cells in the thymus and umbilical cord blood (UCB; Figure 4a ). Although CD161 expression is associated with a memory phenotype, we confirmed that CD161 Figure 4b ). Microarray analysis of naive UCB CD161 int , compared with CD161 neg , CD8 þ T cells from four donors revealed a significant correlation in transcriptional profile with adult memory CD161 int CD8 þ T cells by Gene Set Enrichment Analysis (GSEA) that demonstrated significant (Po0.001) enrichment of those genes upregulated within adult CD161 int CD8 þ T cells (Figure 3) within the CD161 int subset of UCB CD8 þ T cells (Figure 4c) . The naive CD161 int population within UCB again displayed modestly higher expression of IL18Ra (Po0.05), MDR1 (Po0.05), and PLZF (Po0.05) than CD161 neg CD8 þ T cells, as measured by geoMFI, although there was no significant difference in expression of CXCR6 (Figure 4d) . This indicates that, although naive, CD161 int CD8 þ T cells in UCB possess a preprogrammed phenotype reflective of that of CD161 int CD8 þ T cells in the adult circulation.
CD161 int CD8 þ T cells express higher levels of the multidrug efflux pump MDR1 than CD161 neg cells in both UCB (Figure 4d ) and adult blood (Figure 3d) . Furthermore, a greater percentage of the CD161 int population in adult blood expresses this pump compared with the CD161 neg (mean 38.9% vs. 27.65%, respectively) within the memory CD8 þ T-cell pool (Figure 5a) . CD161 hi CD8 þ /MAIT cells have previously been described to express high levels of functional MDR1, enabling them to efflux xenobiotics. 10, 28 Functional activity of MDR1 can be assayed by measuring efflux of the fluorescent substrate Rhodamine 123 (Rh123). 29 Cells loaded with this cell-permeant dye are detected by flow cytometry (loading control; Figure 5b ), with efflux determined by a loss in fluorescence (Efflux; Figure 5b ). High levels of MDR1 activity were confirmed within the CD161 hi population; however, the CD161 int CD8 þ T-cell population also displayed significant (Po0.0001) MDR1 activity. Similar frequencies of CD161 hi CD8 þ T cells were observed before and after efflux (data not shown), suggesting that this was not due to a downregulation of CD161 within the MAIT cell subset. Efflux was inhibited by the addition of MDR1 inhibitors cyclosporin A and verapamil (Figure 5c) . Therefore, CD161 int CD8 þ T cells possess the ability to efflux through the expression of MDR1, which may enable survival within tissues with a high exposure to xenobiotics, such as the gut and liver.
CD161 expression marks polyfunctional antiviral cells equipped with cytotoxic mediators
To examine the specificity of the CD161 int CD8 þ T-cell population, MHC class I dextramers presenting epitopes from cytomegalovirus, Epstein-Barr virus (EBV), and influenza were utilized. These identified a subset of anti-viral CD8 þ T cells specific for each virus to express CD161 in adult peripheral blood (Figure 6a ). Dextramer-positive cells were rarely CD161 hi , as previously described, 10 corresponding to the restriction of CD161
hi MAIT cells to MR1 presenting a bacterial ligand. Approximately 15% of antiviral populations were contained within the CD161 int CD8 þ T-cell population for all three viruses. Furthermore, although the majority of antiviral CD8 þ T cells were CD161 neg , there was no significant difference in terms of frequency within the parent subsets, although there was a trend toward a higher percentage of influenza-specific cells in the CD161 int population (Supplementary Figure S3) .
CD8 þ T cells exert antiviral effects principally through cytokine release and cytotoxicity. The ability of the CD161 int CD8 þ T-cell population to perform these effector functions in comparison with the CD161 neg CD8 þ T-cell population was investigated. As a variety of phenotypic and functional characteristics are associated with differentiation from a naive to memory phenotype, 30 and the majority of CD161 int CD8 þ T cells display a memory phenotype whereas the CD161 neg CD8 þ T-cell population contained a mixture of naive and memory cells (Figure 1c) , naive cells were excluded from all analyses.
Stimulation of CD8 þ T cells with phorbol 12-myristate 13-acetate and ionomycin revealed a significantly greater proportion of the CD161 int CD8 þ T-cell population to express interferon-g (IFNg; Po0.0001) and IL-2 (Po0.05) than the memory CD161 neg CD8 þ population, despite the fact that memory phenotypes are equally distributed between both populations (Figure 1d) . Indeed, significantly (Po0.01) more CD161 int CD8 þ T cells were dual producers of both cytokines (Figure 6b) . In a hypothesis-free approach, phorbol 12-myristate 13-acetate plus ionomcyin-stimulated CD161 int CD8 þ T-cell population were analyzed by mRNA microarray. This revealed the ability to express multiple cytokines and chemokines, including those associated with type 1, 2, and 17 responses (Figure 6c and Supplementary Table S2 ). However, comparison with stimulated CD161 neg CD8 þ T cells did not identify expression of any specific cytokines uniquely produced by the CD161 int population (Supplementary Figure S3 and Supplementary Table S3) .
CD8 þ T cells are considered cytotoxic lymphocytes, with cytotoxicity against target cells mediated through perforin and granzyme B. A significantly larger proportion (Po0.0001) of the CD161 int CD8 þ T-cell population expressed granzyme B (mean 60.74%) compared with the memory CD161 neg CD8 þ T-cell population (mean 44.76%) (Figure 6d) . Moreover, CD161 int CD8 þ T cells expressed significantly (Po0.001) higher levels of perforin (mean 48.83%) than CD161 neg CD8 þ T cells (mean 27.26%), rendering these cells potently equipped for cytotoxic killing. This is in contrast to CD161 hi MAIT cells that lack granzyme B and express low levels of perforin in the resting state (Figure 6d ). The potential of this population to perform multiple functions was probed by cytometry by time-of-flight, which enables the simultaneous measurement of multiple parameters 19 ( Figure 6e) . This demonstrated the ability of the CD161 int CD8 þ T-cell population to express multiple cytotoxic effectors simultaneously, together with the ability to degranulate as assayed by CD107 capture, and to a greater extent than observed within the CD161 neg compartment which showed a greater propensity toward granzyme B expression only. These cytotoxic effectors were also expressed in addition to cytokine. Furthermore, the ability of CD161 int CD8 þ T cells to produce numerous lymphokines, including tumor necrosis factor-a and macrophage inflammatory protein-1b, with a trend toward greater a proportion of cytokine-producing cells than in the CD161 neg compartment, was also observed. Together, this demonstrated the CD161 int CD8 þ T-cell population to be polyfunctional in terms of cytokine and cytotoxic potential.
The transcription factors T-bet and eomesodermin (EOMES) are critical for CD8 þ T-cell effector function, regulating expression of IFNg, granzyme B, and perforin. [32] [33] [34] In line with their enhanced expression of cytokine and cytotoxic effectors, CD161 int CD8 þ T cells expressed significantly more of both EOMES and T-bet than the memory CD161 neg population (Figure 6f ). The generation of potent T cells is a key aim of T-cell vaccine strategies. As intermediate CD161 expression marks highly functional antiviral CD8 þ T cells, we wanted to investigate the potential for T-cell vaccines to induce CD161 int antiviral T cells that reflect this phenotype. A novel recombinant adenoviral vector vaccination strategy was recently described to induce broad and sustained CD8 þ T cells against hepatitis C virus. 35 Examination of these antiviral CD8 þ T cells showed that CD161 was expressed by B18% of these long-lasting cells (Figure 7a) , compared with 15% of bulk CD8 þ T cells. The perforin and granzyme B expression of these antiviral cells, as identified by MHC class I multimers, was analyzed by geoMFI due to small numbers of cells. This revealed that these CD161 int cells expressed significantly (Po0.01) higher levels of granzyme B (Figure 7b ) and perforin (Figure 7c ) compared with antiviral CD161 neg CD8 þ T cells, demonstrating the potential to induce viral-specific CD161 int CD8 þ T cells that reflect the highly functional phenotype of the bulk CD8 þ T-cell subset through vaccination.
DISCUSSION
Delineating the phenotypic diversity contained within the T-cell compartment is of much importance in fully understanding immune mechanisms of both protection and pathology. Here, we describe CD161 to mark potent antiviral memory CD8 þ T cells with enhanced effector function, including cytokine production and, in contrast to CD161 hi /MAIT cells, 31 high expression of cytotoxic mediators in the resting state, related to their elevated expression of T-bet and EOMES. These functional attributes have various implications for antiviral immunity, 30, 36, 37 and thus CD161 may provide a useful marker in tracking CD8 þ T-cell responses in viral disease and following vaccination. Indeed, analysis of antiviral cells induced in a T-cell vaccine strategy targeting hepatitis C virus 35 revealed intermediate CD161 expression in vaccine-induced cells associated with elevated levels of granzyme B and perforin. These T-cell vaccine strategies are now also undergoing clinical trial for induction of protective immunity against Ebola virus.
38
It is interesting to note that Va7.2 þ MAIT cells, although initially termed ''mucosally-associated'' according to a described enrichment within the gut lamina propria, 12 were found here to be relatively rare within the colon, being instead much more predominant within the liver, in agreement with other studies. 10, 23 However, MAIT cells have been detected at high frequencies by MR1-tetramer staining within jejunal mucosa, 13 and this may reflect enrichment of MAIT cells at specific anatomical locations within the gut, 39 with low frequencies in colon. On the other hand, CD161 int CD8 þ T cells were a major population of T cells within the colon and were also enriched, to a similar extent to MAIT cells, within the liver.
As a prominent population within the gut, expression of CD103 and CD69 by CD161 int CD8 þ T cells may function in their retention as T RM cells. 27 Although CD103 and CD69 are considered markers of T RM , 27 the expression of CD161 by this memory population has not yet been investigated. Here, an increase in the percentage of CD161 neg (CD103 À ) cells was observed in inflamed colon tissue, potentially indicative of an influx of these cells, and resulted in the dilution of the CD161 þ (CD103 þ ) population. As CD161 hi MAIT cells are rare within the colon, this CD161 þ population largely corresponds to the CD161 int CD8 þ subset. Together, this could suggest a more stable residence of CD161 int CD8 þ T cells within the colon. This tissue location, together with their antiviral specificity, means that these cells are ideally placed to provide early protection at points of pathogen entry. Indeed, T RM cells are virus-specific cells that persist in tissues after viral infection, where they mediate enhanced protection against reinfection, 2, 3 including through the recruitment of other effector cells. 40 It has recently been shown that once activated, T RM can induce an antiviral state to provide immunity against unrelated viral infections, mediated through IFNg. 40, 41 As CD161 int CD8 þ T cells show an enhanced ability to produce IFNg in response to cytokine stimulation, in the absence of TCR stimulation, 19 this may provide a means by which CD161 int CD8 þ T cells could mediate protection against diverse viral infections. However, the presence of CD161 int CD8 þ T cells within the circulation suggests that this population may be more analogous to the CD4 þ Th17 population described by Kleinschek et al., 42 resident within gut, and also marked by CD161. Analysis of the phenotype of this gut-resident CD161 int CD8 þ T-cell population would provide clues as to their potential roles in homeostasis and pathology. For example, expression of functional MDR1 may facilitate survival of this population within such tissues with a high level of exposure to xenobiotics. Furthermore, as expression of this efflux pump has been associated with resistance to various drugs, including steroids, 43 this has interesting implications for the treatment of conditions such as IBD.
Gene expression analysis of resting CD161 int CD8 þ T cells in peripheral blood revealed expression, at a lower level, of a number of MAIT cell-associated markers, in keeping with CD161 marking cells of a common transcriptional phenotype. 19 Although the upregulation of these markers was modest, we have previously shown that they can still have a functional impact. 19 Interestingly, these markers were also already upregulated in CD161 int CD8 þ T cells within UCB. Preprogramming of CD161-positive cells has previously been described for both CD161 hi CD8 þ 1 and CD161 int CD4 þ
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T cells in UCB, representing precursors of their adult MAIT and Th17 counterparts, respectively. Similarly, there was a significant correlation by GSEA between UCB and adult CD161 int genetic profiles, indicating that CD161 int CD8 þ T cells in UCB represent a naive yet precommitted population. This, together with the fact that CD161 expression is not readily induced on CD161 neg CD8 þ T cells, either upon priming or restimulation 45 (J.R. Fergusson, unpublished data), suggests that these cells represent a distinct population. Here we have shown this population to comprise highly potent memory T cells that reside in tissues including the colon, and which therefore warrant further investigation in the context of control and prevention of viral disease.
METHODS
Cells. All samples were in accordance with the ethical standards of the corresponding committee.
PBMCs were obtained from adults (whole blood leukocyte cones, NHS Blood and Transplant, Oxford, UK), 24 month olds (prospective birth cohort 46 ), and UCB samples (Stem Cell Services, NHS Blood and Transplant).
Healthy liver-derived lymphocytes were obtained as previously described. 23 Colonic tissue was either collected from surgical resections or from biopsies taken during routine colonoscopies. Control samples were taken from uninvolved tissue of patients undergoing surgery for colorectal cancer. Resection material was taken from IBD (both Crohn's disease and ulcerative colitis) patients, undergoing surgery for severe disease, and biopsies from IBD patients were taken either from inflamed involved or normal noninflamed sites based on the judgment of the physicians performing the procedure. Noninflamed samples were also collected from IBD patients with quiescent disease. Details of lymphocyte isolation are detailed in the Supplementary Material. Ethical approval was obtained from the Oxfordshire Research Ethics Committee and informed written consent was given by all study patients.
Thymus samples were obtained after informed consent and ethics committee approval from the University of Oxford and Great Ormond Street Hospital, London. significantly differentially expressed were those genes with a fold change 42 and P-value o0.01. Cord blood microarray analyses were performed as previously described. 1 Heatmaps were generated using GENE-E (http://www.broadinstitute.org/cancer/software/GENE-E/ index.html). GSEA was performed using GSEA version 2.0.14, 48 with CD161 hi /MAIT cell gene sets obtained from GSE62099.
Cytometry by-time-of flight. PBMCs were stimulated as above in the presence of 2.5 mg ml À 1 anti-CD107a, 1.25 mg ml À 1 anti-CD107b (BD Bioscience), and 10 mM TAPI-2 (VWR International, West Sussex, UK). Following stimulation, cells were resuspended in cytometry buffer (phosphate-buffered saline þ 0.05% sodium azide þ 2 mM EDTA þ 2% fetal calf serum) and stained with isotope-tagged antibodies before acquisition on the cytometry by time-of-flight as previously described. 19 Statistical analysis. Statistical analysis was performed using Prism version 6 software (GraphPad, La Jolla, CA). Data are represented as mean ± s.e.m. *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001, NS, not significant P40.05, as stated in figure legends.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
